We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Affirms Patent Ruling on Pfizer's Xalatan
Appeals Court Affirms Patent Ruling on Pfizer's Xalatan
August 23, 2005
The U.S. Court of Appeals for the Federal Circuit has affirmed a 2004 district court ruling that Par Pharmaceutical’s generic version of Pfizer’s glaucoma drug Xalatan infringed on a Pfizer patent for the product.